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Background: The abnormality of interleukin-21 (IL-21)-IL-21-receptor (IL-21R) system has been found in many
autoimmune diseases including autoimmune thyroid diseases (AITDs). In this study, we investigated whether
polymorphisms of the IL-21 and IL-21R are associated with Graves’ disease (GD) and Hashimoto’s thyroiditis (HT),
two major forms of AITDs, among a Chinese population.
Methods: Rs907715, rs4833837, rs2221903 and rs2055979 of the IL-21 gene and rs3093301 and rs2285452 of the
IL-21R gene were explored in a case–control study including 405 GD, 228 HT patients and 242 controls. These
genes were genotyped by the PCR and restriction fragment length polymorphism (RFLP) analysis and the MASS
spectrometry method.
Results: For IL-21 gene, we identified and confirmed a higher prevalence of A alleles of rs2221903 (P = 0.018,
OR = 1.50 95% CI = 1.07-2.09) in GD patients. We also found a significant association between rs2221903 and HT
(allele: P = 0.009, OR = 1.69 95% CI = 1.13-2.51; genotype: recessive P = 0.021, OR = 11.72 95% CI = 1.46-94.13). For the
IL-21R gene, compared with controls, the genotype frequencies of rs3093301 and rs2285452 were significantly
different in HT patients using dominant genetic model (P = 0.023, OR = 1.61 95% CI = 1.07-2.42; P = 0.031, OR = 1.71
95% CI = 1.05-2.80, respectively). Furthermore, the haplotype AA containing the major alleles of rs4833837 and
rs2221903 was associated with increased susceptibility to GD with an OR of 1.50(95% CI =1.08-2.09, P = 0.016), and
to HT with an OR of 1.69(95% CI =1.14-2.52, P = 0.009).
Conclusion: Our results indicated that the SNPs of the IL-21 gene is associated with the development of GD. In
addition, we found that individuals with the SNPs of the common IL-21 and IL-21R may have higher risk of HT.
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nucleotide polymorphism (SNP)Background
Autoimmune thyroid diseases (AITDs), the thyroid-
specific autoimmune disorders, affect about 5% of the
population. The etiology of AITDs includes genetic and
environmental factors resulting in immune abnormality
and the development of AITDs.
In 2000, the interleukin-21(IL-21)-IL21-receptor (IL-
21R) system was discovered [1]. IL-21 and IL-21R are* Correspondence: zhangjinan@hotmail.com
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reproduction in any medium, provided the orlocated on human chromosome 4q26-27 and 16p11, re-
spectively. The IL-21, preferentially produced by CD4 +T
cells, has various functions, such as driving B cells to dif-
ferentiate into memory cells and ultimately plasma cells,
augmenting T cells’ proliferation, and promoting the activ-
ity of natural killer (NK) cells [2]. In accordance with
these roles of IL-21, IL-21R is mainly expressed in B
cells, T cells and NK cells, keratinocytes, and some of
myeloid cells. Animal and clinical studies demonstrated
the dysregulations of IL-21 and IL-21R in autoimmune
diseases. For example, compared with IL-21R-compe-
tent BXSB-Yaa mice for multiple parameters of SLE, theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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malities characteristic of systemic lupus erythematosus
(SLE) [3]. IL-21R is overexpressed in the inflamed syn-
ovial membrane and in peripheral blood or synovial
fluid leukocytes of rheumatoid arthritis (RA) patients
[4]. And the evident increase of serum IL-21 level in
primary Sjogren’s syndrome (pSS) patients has positive
correlation with the levels of gamma-globulin and
erythrocyte sedimentation rate [5].These suggests that
IL-21 and IL-21R may play a critical role in the patho-
genesis of autoimmune diseases. Recently, H.Y. Jia [6]
also reported that an increase of serum IL-21 level in
patients with primary GD.
In recent years, the associations between the IL-21 gene
or IL-21R gene polymorphisms and autoimmune diseases
have been gradually reported. In a HapMap-CEU popula-
tion, a large block (480 kb) of linkage disequilibrium
encompassing KIAA1109/Tenr/IL2/IL21 showed genetic
associations with type 1 diabetes mellitus (T1DM) [7,8],
RA [8], juvenile idiopathic arthritis (JIA) [9], psoriasis and
psoriatic arthritis(PA) [10]. Similarly, the polymorphisms
of the IL2/IL21 gene region likely to confer to the suscep-
tibility to coeliac disease in Scandinavia families [11] and a
US population [12], to ulcerative colitis in a North Ameri-
can and an Italian cohort [13], and to multiple sclerosis in
a Spanish population [14]. After the SNPs in the IL-21
gene were analyzed, the significant differences of rs907715
and rs2221903 allele and genotype frequencies were found
between SLE and controls [15]. In addition to these re-
ports, an association between microsatellite polymor-
phisms of the IL-21R and diabetes in Japanese patients,
between rs3093301 and rs2285452 in the IL-21R gene re-
gion and SLE in the European-derived cohort were docu-
mented [16].
Therefore, it is reasonable to speculate that IL-21 and
IL-21R are the candidate genes for AITDs. Plagnol [17]
reported that the rs2069763 in chromosome 4q27 were as-
sociated with the GD susceptibility in a Caucasian cohort.
And a recent study that indicated that rs907715 of IL-21
gene was associated with GD in a Chinese population [6].
In this study, additional variants of the IL-21 gene and
two SNPs of the IL-21R gene in addition to previously
reported variants were investigated in two subtypes of
AITDs including GD and HT.
Methods
Patients and controls
AITDs patients and healthy controls were enrolled from
the First Affiliated Hospital, Medical School of Xi’an
Jiaotong University. A total of 633 independent patients
with AITDs, including 405 GD and 228 HT, and 242 unre-
lated healthy controls were recruited. GD and HT were
diagnosed based on clinical and laboratory evidence of
hyperthyroidism and hypothyroidism respectively and diffusegoitre, supported by the presence of antithyroglobulin
antibody (TgAb) and/or antithyroid peroxidase anti-
body (TPOAb) and/or exophthalmos. The controls were
healthy subjects without clinical evidence or family history
of any AITDs. This study was approved by the ethics com-
mittee of Jinshan hospital of Fudan University. All patients
and control subjects were asked to sign an informed
consent.
Genotyping
Genomic DNA was extracted from peripheral blood leu-
kocytes using the Nucleon Bacc kit from TianGen Bio-
tech CO. LTD (Beijing, China).
Rs907715, rs4833837, rs2221903 and rs2055979 span-
ning a large region which captured all common variation
in the IL-21 gene and rs3093301 and rs2285452 which
were only two tag-SNPs of IL-21R gene confirmed to be
associated with SLE in European-derived cohort
were selected from the published SNP database
(http://www.ncbi.nlm.nih.gov/SNP). All of these SNPs
were validated polymorphisms, and have a minor allele
frequency(MAF) of more than 1%. Rs907715, rs4833837,
and rs222190 are located on intron 2 of IL-21R and
rs2055979 on intron 3. For IL-21R gene, rs3093301 is in
intron 2 and rs2285452 in exon 10.
All of the four IL-21 SNPs and rs2285452 were typed
using mass spectrometry method (Shanghai Benegene
Biotechnologies CO. Ltd. Shanghai, China). Rs3093301
was typed using PCR-restriction fragment length poly-
morphism (PCR-RELP) method. The appropriate frag-
ment of rs3093301 in the IL-21R gene was amplified
using specific primers (forward: 5′-AATTGCTCCT
CAGCAGATCC-3′, reverse: 5′-GCATCAGCCTCCC
GAGTAG-3′). The PCR reaction was performed in a
25μl mixture, containing 100ng genomic DNA and 0.1
mM solution of each primer, 12.5 μl 2*Taq PCR
MasterMix (TianGen Biotech CO. LTD, Beijing, China)
and 9.5 μl ddH2O. PCR was carried out with initial de-
naturation for 5 min at 95°C, followed by 37 cycles of
annealing for 30 seconds at 60°C, extension for 30 seconds
at 72°C and denaturation for 30 seconds, and a final exten-
sion for 5 min at 72°C. The product (383 bp) was digested
with restriction enzyme NIaIII (Fermentas Life Sciences)
at 37 centigrade for 10 hours, and analyzed on a 3% agar-
ose gel. There were three profiles of the digested fragments:
210 bp, 44 bp, and 129 bp indicating the presence of TT,
two fragments of 254 bp and 129 bp indicating the
presence of CC, and four fragments of 254 bp, 210 bp,
129 bp and 44 bp representing TC genotype.
Statistical analysis
In this study, we used a population-based case–control
method. Statistical analysis was performed using Haploview
4.1 and SPSS 11.0. Hardy-Weinberg equilibrium (HWE) of
Table 1 Allele distributions and HWE P value of the four SNPs in IL21 gene and two SNPs in IL-21R gene
SNP ID
HWE P value Associated
allele
Count (frequency %) GD P value
(OR,95% CI)
HT P value
(OR,95% CI)Control GD HT Control GD HT
IL-21
rs907715 0.634 0.968 0.085 A 208(44.6) 348(44.5) 210(46.9) 0.963 0.497
rs4833837 0.999 0.300 0.715 G 56(11.6) 86(10.6) 44(9.6) 0.606 0.340
rs2221903 0.055 0.329 0.715 A 405(84.7) 721(89.2) 412(90.4) 0.018 (1.50, 1.07-2.09) 0.009 (1.69,1.13-2.51)
rs2055979 0.507 0.999 0.484 T 186(38.9) 312(39.7) 160(36.5) 0.782 0.458
IL-21R
rs3093301 0.427 0.732 0.172 T 228(47.1) 387(48.0) 192(42.3) 0.752 0.138
rs2285452 0.326 0.510 0.830 A 55(11.3) 89(11.0) 36(7.9) 0.797 0.068
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test. Categorical data were analyzed by chi-square or
Fisher’s exact test. For continuous data, Student’s t-test was
used for the normalized data, and non-parametric test was
used for non-normalized data. Furthermore, corrected
P value and gene-gene interaction were analyzed using lo-
gistic regression analysis. In this study, a two-tailed P value
less than 0.05 was considered to be significantly difference.
Results
Four SNPs (rs907715, rs4833837, rs2221903 and
rs2055979) of the IL-21 gene and two SNPs
(rs3093301 and rs2285452) of the IL-21R gene were
typed in 405 GD and 228 HT patients and 242 con-
trols. For the tested SNPs, genotyping successful rate
was more than 96.9%. All of the 6 genotyped SNPs
showed a MAF more than 7% and HWE analysis in the
three groups showed P values of more than 0.05 (seen
in Table 1). When comparing age and sex distributions
between patients and controls, we found the control
group matched well with the GD group, but not with
HT group (seen in Table 2). The distributions of the
SNPs genotypes in HT patients were analyzed using
logistic regression analysis adjusted for sex and age
when compared with the controls.
Association of the IL-21 gene polymorphisms with GD
and HT
A genetic association between GD and HT and one of the
four genotyped IL-21 SNPs was found in this study. For
the SNP rs2221903 located in the intron 2 regions, the fre-
quency of A allele was 89.2% in GD and 90.4% in HT,Table 2 Age and sex characteristics of GD and HT patients an
Group
Age
Kolmogorov - Smirnov P value Z score
control <0.001 –
GD <0.001 -0.487
HT 0.200 -2.599respectively, significantly higher than 84.7% in healthy
controls (GD: P = 0.018, OR = 1.495 95% CI = 1.070-2.086;
HT: P = 0.009, OR = 1.69 95% CI = 1.13-2.51). In contrast
to these results, the allele frequencies of rs907715,
rs4833837 and rs2055979 were similar between patients
and controls (Table 1). As the distributions of rs907715,
rs4833837, rs2221903 and rs2055979 genotypes in pa-
tients and controls are shown in Table 3. For rs2221903,
the frequencies of the genotypes carrying risk allele (A)
were higher both in GD (AA: 80.2%, GA: 18.1%) and
HT (AA: 81.1%, GA:18.4%) patients than in controls
(AA: 73.6%, GA: 22.2%), but statistical significance was
only found when the recessive genetic model was used
in HT patients (AA + GA vs. GG, P = 0.021, OR = 11.72
95% CI = 1.46-94.13), in comparison with the controls. In
this study, no significant association was observed be-
tween GD or HT and rs907715, rs4833837 or rs2055979
genotypes while different genetic models were applied for
analysis.
Association of the IL-21R gene polymorphisms with GD
and HT
As shown in Table 1, the rs3093301 and rs2285452
SNPs in IL-21R showed no association with GD or HT
(P = 0.797-0.068).
Nominal associations were found between rs3093301
and rs2285452 and HT when the dominant genetic
model (CC vs. TC + TT, P = 0.023, OR = 1.61 95% CI =
1.070-2.42); GG vs. GT + TT, P = 0.031, OR = 1.71 95%
CI = 1.05-2.80, respectively) was used for analysis.
Genotype analysis of rs3093301 and rs2285452 using
additive and recessive genetic model did not indicated controls
Sex
P value Male/female counts χ2 P value
– 67/175 – –
0.626 114/291 0.016 0.899
0.009 27/201 18.410 1.7E-5































0.334 0.568 0.264GA 120(51.5) 192(49.1) 98(43.8)





0.67 0.667 0.401GA 50(20.7) 72(17.8) 42(18.4)









GA 53(22.2) 73(18.1) 42(18.4)





0.731 0.455 0.572GT 108(45.2) 188(47.8) 96(43.8)









0.896TC 128(52.9) 197(48.9) 100(44.1)








0.435GA 52(21.8) 83(20.5) 32(14.1)
AA 1(0.4) 3(0.7) 2(0.9)
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trols (Table 3). For rs3093301 and rs2285452, no signifi-
cant different distribution was found in GD patients
and controls when different genetic models was used
(showed by Table 3).
Haplotype analysis in GD and HT
As shown in Table 4, rs4833837 and rs2221903
(r-square = 0.901) were identified as an LD block
using the Haploview 4.1. The total frequency of haplo-
types listed in Table 5 was more than 99.0% in every
group. AA containing major alleles of these two SNPs
was associated with increased susceptibility to GD with
an OR of 1.50 (95% CI =1.08-2.09, P = 0.016), and to HTTable 4 The linkage disequilibrium analysis of the SNPs
in IL-21 and IL-21R gene
r-square
IL-21 rs4833837 rs2221903 rs2055979
rs907715 0.099 0.090 0.493
rs4833837 – 0.901 0.067
rs2221903 – – 0.059
IL-21R rs2285452
rs3093301 0.369(0.018)with an OR of 1.69 (95% CI =1.14-2.52, P = 0.009)
(Table 5).
Discussion
IL-21 is a member of the common-gamma chain family of
cytokines with immunoregulatory activity. IL-21R has been
shown to form a heterodimeric receptor complex with the
common gamma-chain. IL-21 binding with this receptor
leads to the activation of multiple downstream signaling
molecules, including JAK1, JAK3, STAT1 and STAT3,
therefore affects the innate and adaptive immune responses
by inducing the differentiation, proliferation and activity of
multiple target cells. The dysregulation of IL-21 and IL-21R
plays a role in multiple immune-mediated diseases, includ-
ing SLE [3], psoriasis [5], RA [4] and other chronic inflam-
matory diseases [18]. Like other autoimmune diseases, GD
and HT are chronic diseases initiated by the loss of im-
munological tolerance to self-antigens. Previous studies in-
dicate that some immune-related genes may participate in
the development of AITDs.
In this study, we found a significant association be-
tween GD or HT and rs2221903 located in the IL-21
gene region, and the frequencies of the haplotypes in the
IL-21 gene that consists of rs4833837 and rs2221903 in
GD and HT patients were significantly different from
Table 5 The frequencies of the haplotypes of IL-21 gene in patients and controls
Reference SNP Frequency % GD HT
rs4833837 rs2221903 Control GD HT p OR (95% CI) p OR (95% CI)
A A 84.7 89.3 90.4 0.016 1.500 (1.08-2.09) 0.009 1.694 (1.14-2.52)
G G 11.6 10.7 9.6 0.640 0.92 (0.64-1.31) 0.340 0.816 (0.54-1.24)
A G 3.7 0.0 0.0 4.0E-8 – 4.0E-4 –
Zhang et al. BMC Endocrine Disorders 2013, 13:26 Page 5 of 6
http://www.biomedcentral.com/1472-6823/13/26controls. For rs3093301 and rs2285452 polymorphisms
of the IL-21R gene, there were significantly different dis-
tributions of these genotypes between HT patients and
the controls.
In different from Jia’s study [6], we did not find the
rs907715 SNP linkage with GD. In Jia’s report, the AA
genotype frequency was lower in GD patients (19.4%) than
in controls (30%). The gene frequency in patients of our
study was similar to that of Jia’s study, but different in the
two control groups. In our study the frequency of AA
genotype in the control group was 18.9%, which is similar
to the frequency in the HapMap-CHB population. This
may be the geographical or selection variation that results
in this difference. It should be noted that the lack of associ-
ation in our study does not completely exclude the possi-
bility of IL-21R as a candidate gene for GD because of the
following three reasons: 1) The average MAF of the six
SNPs is 0.271, which gives our study genetic power of
about 0.8 for GD and 0.7 for HT group with an OR of
homozygote 2.0, and of heterozygote 1.5, therefore studies
with a larger sample size are necessary to confirm whether
patients with these SNPs have more risk for development
of GD. 2) As many other immunologic disorders, AITDs is
believed to derive from a multiple network of various sus-
ceptible loci, which exert synergic or additive effects, but
each locus may play a small role [19]. 3) 13 tag-SNPs in
the HapMap-CHB population and 17 in the HapMap-CEU
population covered a 49.8 kb on 16p11, where IL-21R gene
located. And we just explored the association between the
two tag-SNPs of them and AITDs in Chinese cohort.
In genetics, a recessive gene is an allele that causes a
phenotype (visible or detectable characteristic) that is only
seen in a homozygous genotype (an organism that has two
copies of the same allele) and never in a heterozygous
genotype. While dominance is a relationship between al-
leles of a gene, in which one allele masks the expression
(phenotype) of another allele at the same locus. Our study
didn’t find any synergistic effect of the risk genotype. And
we were unable to conclude whether these two genes were
either recessive or dominant over the other gene.
IL-21 is located on chromosome 4q26-27, which is
close to IL-2, a region that has been linked to AITDs
susceptibility [17]. Jia’s et al. found rs907715 of IL-21
gene being associated with GD in a Chinese population
while Plagnol found only rs2069763 and did not find as-
sociation of rs2069762 and rs6822844 of IL-2 with GD,maybe there is ethnicity or regional effect contributing
to these results differences. Therefore, we can not
exclude that the SNPs of the IL-21 and IL-21R genes are
only an indicator of a candidate gene contributing
to AITDs. Further studies such as screening the rest
common variations in IL21R gene, identifying the cau-
sal SNP for this association, and exploring gene-
environment interaction in GD and HT cohort studies
are required to clarify the effect of IL-21 and IL-21R on
AITDs susceptibility. Replication of these associations
between IL-21 and IL-21R gene and AITDs is also re-
quired in larger independent databases of different
cohorts.
Conclusion
In conclusion, our study confirmed the synergic effect of
the IL-21 SNPs in the development of GD. In addition,
to the best of our knowledge, we are the first to report
the association of the IL-21 and IL-21R SNPs with an in-
creased risk of HT.
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